Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$6.81 - $9.23 $14,301 - $19,383
-2,100 Reduced 12.57%
14,600 $118,000
Q1 2021

May 18, 2021

BUY
$7.99 - $15.0 $133,433 - $250,500
16,700 New
16,700 $139,000
Q3 2020

Nov 17, 2020

SELL
$9.98 - $18.04 $747,502 - $1.35 Million
-74,900 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$7.49 - $15.16 $561,001 - $1.14 Million
74,900 New
74,900 $1.14 Million
Q1 2018

May 15, 2018

SELL
$22.55 - $29.9 $326,975 - $433,550
-14,500 Closed
0 $0
Q4 2017

Feb 15, 2018

BUY
$18.0 - $30.0 $261,000 - $435,000
14,500
14,500 $380,000

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.